Stay updated on Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.

Latest updates to the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page
- Check6 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3. No substantive changes to study details or procedures are evident in the screenshots.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedNew site revision added: Revision: v3.4.2. The previously displayed notice about government funding lapse and the older Revision: v3.4.1 text were removed.SummaryDifference0.5%

- Check41 days agoChange DetectedA new site-wide notice about a lapse in government funding was added, and the page revision shows version 3.4.1 (replacing 3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedShow glossary toggle is now visible. Minor wording changes include capitalization tweaks for 'Last Update' and 'No FEAR Act' data, plus a new footer tag 'Revision: v3.4.0'.SummaryDifference0.2%

- Check62 days agoChange DetectedSite revision updated from v3.3.3 to v3.3.4; no user-facing content changes to the Study Details page were observed.SummaryDifference0.1%

- Check84 days agoChange DetectedAdded a Locations section with the Pittsburgh, PA site and updated the page revision to v3.3.3; removed the HHS Vulnerability Disclosure and the previous Pennsylvania Locations reference.SummaryDifference0.2%

Stay in the know with updates to Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Valoctocogene Roxaparvovec in Hemophilia A Clinical Trial page.